A novel combination therapy drastically reduces the infection rate of three viruses – and risk of death – in transplant patients with compromised immune systems. The findings, to be reported in the Nov. 1 print edition of Nature Medicine, originate from a study conducted at Baylor College of Medicine, The Methodist Hospital, and Texas Children’s Hospital. >>> Discuss This Story
